1. CP-158 Uncritical use of proton pump inhibitors in non-intensive care units of a university hospital. (14th February 2016) Authors: Fritsch, A; Eckstein, B; Brunnert, M; Baehr, M; Langebrake, C; Hilgarth, H Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of single‐cell biomechanics as potential marker for oral squamous cell carcinomas: a pilot study. (6th September 2013) Authors: Runge, J; Reichert, TE; Fritsch, A; Käs, J; Bertolini, J; Remmerbach, TW Journal: Oral diseases Issue: Volume 20:Number 3(2014:Apr.) Page Start: e120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer. (13th July 2017) Authors: Diekstra, MH; Fritsch, A; Kanefendt, F; Swen, JJ; Moes, DJAR; Sörgel, F; Kinzig, M; Stelzer, C; Schindele, D; Gauler, T; Hauser, S; Houtsma, D; Roessler, M; Moritz, B; Mross, K; Bergmann, L; Oosterwijk, E; Kiemeney, LA; Guchelaar, HJ; Jaehde, U Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 9(2017) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗